Decreased IL‐33 Expression in the Cervix in LPS‐Induced Preterm Birth and the Potential Role of Mast Cells: A Murine Model
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70085 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Sema Avci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Alanya Alaaddin Keykubat University, School of Medicine, Antalya, Turkey. Hauptthemen laut MEDLINE: Premature Birth, Interleukin-33, Mast Cells, Cervix Uteri. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Scientific and Technological Research Council of Turkey, Türkiye Bilimsel ve Teknolojik Araştirma Kurumu.
Abstract (Originalsprache)
Problem In order to gain a deeper understanding of the mechanisms underlying LPS‐mediated preterm birth, it is crucial to investigate the relationship between preterm birth and mast cells (MCs). Moreover, the role of antihistamines in inflammatory processes during pregnancy remains incompletely understood. Method of Study CD‐1 female mice were administered intrauterine lipopolysaccharide (LPS) via midline laparotomy to establish an inflammation‐induced preterm birth model. The experimental groups ( n = 6 per group) were formed as Nonpregnant and pregnant control, Sham, PBS, LPS, Cetirizine (CET) control, and two CET treatment groups (CET 10 mg/kg‐low dose, and CET 20 mg/kg‐high dose with LPS administration). Tissue samples were analyzed using immunohistochemistry and Western blot techniques.
Results
Our findings suggest that MCs play a significant role in preterm birth, with LPS administration inducing MC dysfunction in the reproductive tract during pregnancy. Additionally, high doses of CET may support inflammatory responses. A particularly notable result was the reduction in interleukin‐33 (IL‐33) expression in the cervix during LPS‐induced preterm birth. This suggests that IL‐33 may serve as a potential biomarker for preterm birth in the cervix.
Conclusions
The effects of CET during LPS‐mediated preterm birth appear to be dose‐dependent, warranting further exploration of their role in this context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Alanya Alaaddin Keykubat University, School of Medicine, Antalya, Turkey.
- Department of Histology and Embryology, Koc University, School of Medicine, Istanbul, Turkey.
- Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.
- Department of Histology and Embryology, Akdeniz University, School of Medicine, Antalya, Turkey.
ORCID-Profile: Sema Avci, Ciler Celik-Ozenci, Nilay Kuscu, Nayce Ilayda Bektas
Förderung
- Scientific and Technological Research Council of Turkey
- Türkiye Bilimsel ve Teknolojik Araştirma Kurumu
Zitieren
APA
Avci, S., Celik-Ozenci, C., Kuscu, N., & Bektas, N. I. (2025). Decreased IL‐33 Expression in the Cervix in LPS‐Induced Preterm Birth and the Potential Role of Mast Cells: A Murine Model. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70085
Vancouver
Avci S, Celik-Ozenci C, Kuscu N, Bektas NI. Decreased IL‐33 Expression in the Cervix in LPS‐Induced Preterm Birth and the Potential Role of Mast Cells: A Murine Model. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70085
BibTeX
@article{Avci2025,
author = {Avci, Sema and Celik-Ozenci, Ciler and Kuscu, Nilay and Bektas, Nayce Ilayda},
title = {Decreased IL‐33 Expression in the Cervix in LPS‐Induced Preterm Birth and the Potential Role of Mast Cells: A Murine Model},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70085}
}
EUVIMED